Werner, Stephanie G. http://orcid.org/0000-0002-6566-3740
Baraliakos, Xenofon
Reckert, Sabine
Bohl-Bühler, Martin
Laliberté, Marie-Claude http://orcid.org/0000-0003-0178-1331
Girard, Tanya
Jeromin, Katharina
Baschuk, Nikola
Fritz, Björn
Bessette, Louis http://orcid.org/0000-0002-6834-2731
Hueber, Axel J. http://orcid.org/0000-0001-6454-1234
Clinical trials referenced in this document:
Documents that mention this clinical trial
Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice
https://doi.org/10.1007/s40744-023-00589-3
Article History
Received: 28 April 2023
Accepted: 28 July 2023
First Online: 11 September 2023
Declarations
:
: Axel J Hueber consultant or speaker: Abbvie, BMS, Eli Lilly, Galapagos, Gilead, Novartis, UCB; Funding for investigator-initiated studies: Novartis. Stephanie G Werner consultant/honoraria: Abbvie, Janssen-Cilag, Lilly, Pfizer, UCB. Xenofon Baraliakos consultant, speakers bureau, scientific advisory board and honoraria: Abbvie, Amgen, BMS, Chugai, Galapagos, Gilead, Lilly, MSD, Novartis, Pfizer, Roche, Sandoz, UCB. Sabine Reckert participated in non-interventional trials of AbbVie and declares no further conflicts of interest. Martin Bohl-Bühler participated in non-interventional trials of AbbVie GmbH & Co. KG, AMS Advanced Medical Services GmbH, BMS via inVentiv Health Clinical#, Charité Universitätsmedizin Berlin, Covance Inc., Galapagos, MSD SHARP & DOHME GMBH, Novartis Pharma GmbH, Pfizer Pharma GmbH, PPD Global Ltd, Rheumatologische Fortbildungsakademie, Roche Pharma AG, Sanofi-Aventis Deutschland GmbH, UCB Biosciences GmbH, Winicker Norimed GmbH and received honoraria for lectures and participation in advisory boards from AbbVie Deutschland GmbH & Co. KG, Amgen GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Galapagos Biopharma Germany GmbH, Gilead Sciences Europe Ltd., GILEAD Sciences GmbH, Hexal AG, Janssen-Cilag GmbH, Lilly Deutschland GmbH, MICE Service GmbH für Mylan Germany Team, MSD SHARP & DOHME GMBH, Novartis Pharma GmbH, Roche Pharma AG, Theramex Germany GmbH, UCB Pharma GmbH. Louis Bessette Speaker: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Lilly, Novartis, Sanofi, Sandoz, Fresenius Kabi, Teva, Organon, JAMP Pharma; Consultant: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Lilly, Novartis, Sanofi, Sandoz, Fresenius Kabi, Teva, Organon, JAMP Pharma; Research: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Celgene, Sanofi, Lilly, Novartis, Gilead, JAMP Pharma. Marie-Claude Laliberté, Nikola Baschuk, Katharina Jeromin, Björn Fritz and Tanya Gerard are employees of AbbVie Corporation and may own AbbVie stocks and/or options.
: Institutional review board approval for the conduct of this study was obtained from the Friedrich-Alexander-University Erlangen-Nürnberg (# 458_20 B) on 8 December 2020. The study was performed according to the Declaration of Helsinki and its later amendments. All subjects provided informed consent to participate in the study.